IXJ holdings
iShares Global Healthcare ETF
Positions
124 stored of 124 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY AND COMPANY ELI LILLY CO | US5324571083 | 532457108 | 10.930% | $420.3M | Equity (common) | Corporate | United States | USD |
| 2 | JOHNSON & JOHNSON | US4781601046 | 478160104 | 7.043% | $270.8M | Equity (common) | Corporate | United States | USD |
| 3 | ABBVIE INC. | US00287Y1091 | 00287Y109 | 5.122% | $196.9M | Equity (common) | Corporate | United States | USD |
| 4 | UNITEDHEALTH GROUP INCORPORATED | US91324P1021 | 91324P102 | 4.395% | $169.0M | Equity (common) | Corporate | United States | USD |
| 5 | MERCK & CO., INC. | US58933Y1055 | 58933Y105 | 4.120% | $158.4M | Equity (common) | Corporate | United States | USD |
| 6 | ASTRAZENECA PLC | GB0009895292 | Not reported | 3.759% | $144.5M | Equity (common) | Corporate | United Kingdom | GBP |
| 7 | Roche Holding AG | CH1499059983 | Not reported | 3.749% | $144.2M | Equity (common) | Corporate | Switzerland | CHF |
| 8 | Novartis AG | CH0012005267 | Not reported | 3.714% | $142.8M | Equity (common) | Corporate | Switzerland | CHF |
| 9 | AMGEN INC. | US0311621009 | 031162100 | 2.537% | $97.5M | Equity (common) | Corporate | United States | USD |
| 10 | THERMO FISHER SCIENTIFIC INCORPORATED | US8835561023 | 883556102 | 2.418% | $93.0M | Equity (common) | Corporate | United States | USD |
| 11 | ABBOTT LABORATORIES | US0028241000 | 002824100 | 2.052% | $78.9M | Equity (common) | Corporate | United States | USD |
| 12 | GILEAD SCIENCES, INC. | US3755581036 | 375558103 | 2.036% | $78.3M | Equity (common) | Corporate | United States | USD |
| 13 | NOVO NORDISK A/S | DK0062498333 | Not reported | 1.987% | $76.4M | Equity (common) | Corporate | Denmark | DKK |
| 14 | INTUITIVE SURGICAL, INC. | US46120E6023 | 46120E602 | 1.828% | $70.3M | Equity (common) | Corporate | United States | USD |
| 15 | PFIZER INC. | US7170811035 | 717081103 | 1.782% | $68.5M | Equity (common) | Corporate | United States | USD |
| 16 | CVS HEALTH CORPORATION | US1266501006 | 126650100 | 1.714% | $65.9M | Equity (common) | Corporate | United States | USD |
| 17 | VERTEX PHARMACEUTICALS INCORPORATED | US92532F1003 | 92532F100 | 1.637% | $62.9M | Equity (common) | Corporate | United States | USD |
| 18 | DANAHER CORPORATION | US2358511028 | 235851102 | 1.558% | $59.9M | Equity (common) | Corporate | United States | USD |
| 19 | BRISTOL-MYERS SQUIBB COMPANY | US1101221083 | 110122108 | 1.528% | $58.7M | Equity (common) | Corporate | United States | USD |
| 20 | STRYKER CORPORATION | US8636671013 | 863667101 | 1.410% | $54.2M | Equity (common) | Corporate | United States | USD |
| 21 | GSK PLC | GB00BN7SWP63 | Not reported | 1.382% | $53.1M | Equity (common) | Corporate | United Kingdom | GBP |
| 22 | MEDTRONIC PUBLIC LIMITED COMPANY MEDTRONIC PLC | IE00BTN1Y115 | G5960L103 | 1.304% | $50.1M | Equity (common) | Corporate | Ireland | USD |
| 23 | SANOFI SA | FR0000120578 | Not reported | 1.184% | $45.5M | Equity (common) | Corporate | France | EUR |
| 24 | MCKESSON CORPORATION | US58155Q1031 | 58155Q103 | 1.179% | $45.3M | Equity (common) | Corporate | United States | USD |
| 25 | ELEVANCE HEALTH, INC. | US0367521038 | 036752103 | 1.090% | $41.9M | Equity (common) | Corporate | United States | USD |
| 26 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | US0669225197 | 066922519 | 1.056% | $40.6M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 27 | THE CIGNA GROUP CIGNA GROUP THE | US1255231003 | 125523100 | 0.947% | $36.4M | Equity (common) | Corporate | United States | USD |
| 28 | BOSTON SCIENTIFIC CORPORATION | US1011371077 | 101137107 | 0.824% | $31.7M | Equity (common) | Corporate | United States | USD |
| 29 | REGENERON PHARMACEUTICALS, INC. | US75886F1075 | 75886F107 | 0.809% | $31.1M | Equity (common) | Corporate | United States | USD |
| 30 | HCA HEALTHCARE, INC. | US40412C1018 | 40412C101 | 0.786% | $30.2M | Equity (common) | Corporate | United States | USD |
| 31 | argenx SE | NL0010832176 | Not reported | 0.744% | $28.6M | Equity (common) | Corporate | Netherlands | EUR |
| 32 | CARDINAL HEALTH, INC. | US14149Y1082 | 14149Y108 | 0.722% | $27.8M | Equity (common) | Corporate | United States | USD |
| 33 | CENCORA, INC. | US03073E1055 | 03073E105 | 0.715% | $27.5M | Equity (common) | Corporate | United States | USD |
| 34 | ESSILORLUXOTTICA SA | FR0000121667 | Not reported | 0.711% | $27.4M | Equity (common) | Corporate | France | EUR |
| 35 | Bayer Aktiengesellschaft BAYER AG | DE000BAY0017 | Not reported | 0.705% | $27.1M | Equity (common) | Corporate | Germany | EUR |
| 36 | HOYA CORPORATION | JP3837800006 | Not reported | 0.700% | $26.9M | Equity (common) | Corporate | Japan | JPY |
| 37 | EDWARDS LIFESCIENCES CORPORATION | US28176E1082 | 28176E108 | 0.676% | $26.0M | Equity (common) | Corporate | United States | USD |
| 38 | Takeda Pharmaceutical Company Limited TAKEDA PHARMACEUTICAL CO LTD | JP3463000004 | Not reported | 0.659% | $25.3M | Equity (common) | Corporate | Japan | JPY |
| 39 | HUMANA INC. | US4448591028 | 444859102 | 0.619% | $23.8M | Equity (common) | Corporate | United States | USD |
| 40 | Lonza Group AG | CH0013841017 | Not reported | 0.615% | $23.6M | Equity (common) | Corporate | Switzerland | CHF |
| 41 | Galderma Group AG | CH1335392721 | H3301B107 | 0.541% | $20.8M | Equity (common) | Corporate | Switzerland | CHF |
| 42 | IDEXX LABORATORIES, INC. | US45168D1046 | 45168D104 | 0.539% | $20.7M | Equity (common) | Corporate | United States | USD |
| 43 | BECTON, DICKINSON AND COMPANY BECTON DICKINSON CO | US0758871091 | 075887109 | 0.539% | $20.7M | Equity (common) | Corporate | United States | USD |
| 44 | HALEON PLC | GB00BMX86B70 | Not reported | 0.530% | $20.4M | Equity (common) | Corporate | United Kingdom | GBP |
| 45 | Sandoz Group AG | CH1243598427 | Not reported | 0.516% | $19.8M | Equity (common) | Corporate | Switzerland | CHF |
| 46 | CSL LIMITED CSL LTD | AU000000CSL8 | Not reported | 0.503% | $19.3M | Equity (common) | Corporate | Australia | AUD |
| 47 | AGILENT TECHNOLOGIES, INC. | US00846U1016 | 00846U101 | 0.487% | $18.7M | Equity (common) | Corporate | United States | USD |
| 48 | WATERS CORPORATION | US9418481035 | 941848103 | 0.478% | $18.4M | Equity (common) | Corporate | United States | USD |
| 49 | UCB SA | BE0003739530 | Not reported | 0.469% | $18.0M | Equity (common) | Corporate | Belgium | EUR |
| 50 | Otsuka Holdings Co., Ltd. | JP3188220002 | Not reported | 0.445% | $17.1M | Equity (common) | Corporate | Japan | JPY |
| 51 | Alcon AG ALCON INC | CH0432492467 | Not reported | 0.437% | $16.8M | Equity (common) | Corporate | Switzerland | CHF |
| 52 | IQVIA HOLDINGS INC | US46266C1053 | 46266C105 | 0.419% | $16.1M | Equity (common) | Corporate | United States | USD |
| 53 | BIOGEN INC. | US09062X1037 | 09062X103 | 0.414% | $15.9M | Equity (common) | Corporate | United States | USD |
| 54 | DAIICHI SANKYO COMPANY, LIMITED DAIICHI SANKYO CO LTD | JP3475350009 | Not reported | 0.396% | $15.2M | Equity (common) | Corporate | Japan | JPY |
| 55 | ZOETIS INC. | US98978V1035 | 98978V103 | 0.391% | $15.0M | Equity (common) | Corporate | United States | USD |
| 56 | CENTENE CORPORATION | US15135B1017 | 15135B101 | 0.391% | $15.0M | Equity (common) | Corporate | United States | USD |
| 57 | CHUGAI PHARMACEUTICAL CO., LTD. | JP3519400000 | Not reported | 0.383% | $14.7M | Equity (common) | Corporate | Japan | JPY |
| 58 | GE HEALTHCARE TECHNOLOGIES INC. | US36266G1076 | 36266G107 | 0.378% | $14.5M | Equity (common) | Corporate | United States | USD |
| 59 | RESMED INC. | US7611521078 | 761152107 | 0.367% | $14.1M | Equity (common) | Corporate | United States | USD |
| 60 | VEEVA SYSTEMS INC. | US9224751084 | 922475108 | 0.346% | $13.3M | Equity (common) | Corporate | United States | USD |
| 61 | DEXCOM, INC. | US2521311074 | 252131107 | 0.337% | $13.0M | Equity (common) | Corporate | United States | USD |
| 62 | METTLER-TOLEDO INTERNATIONAL INC. | US5926881054 | 592688105 | 0.335% | $12.9M | Equity (common) | Corporate | United States | USD |
| 63 | WEST PHARMACEUTICAL SERVICES, INC. | US9553061055 | 955306105 | 0.329% | $12.7M | Equity (common) | Corporate | United States | USD |
| 64 | MODERNA, INC. | US60770K1079 | 60770K107 | 0.321% | $12.3M | Equity (common) | Corporate | United States | USD |
| 65 | Astellas Pharma Inc. | JP3942400007 | Not reported | 0.314% | $12.1M | Equity (common) | Corporate | Japan | JPY |
| 66 | QUEST DIAGNOSTICS INCORPORATED | US74834L1008 | 74834L100 | 0.305% | $11.7M | Equity (common) | Corporate | United States | USD |
| 67 | LABCORP HOLDINGS INC. | US5049221055 | 504922105 | 0.298% | $11.5M | Equity (common) | Corporate | United States | USD |
| 68 | MERCK Kommanditgesellschaft auf Aktien MERCK KGAA | DE0006599905 | Not reported | 0.281% | $10.8M | Equity (common) | Corporate | Germany | EUR |
| 69 | Koninklijke Philips N.V. | NL0000009538 | Not reported | 0.275% | $10.6M | Equity (common) | Corporate | Netherlands | EUR |
| 70 | STERIS PUBLIC LIMITED COMPANY STERIS PLC | IE00BFY8C754 | G8473T100 | 0.268% | $10.3M | Equity (common) | Corporate | Ireland | USD |
| 71 | BeOne Medicines AG BEONE MEDICINES LTD | CH1391448177 | Not reported | 0.267% | $10.3M | Equity (common) | Corporate | Switzerland | HKD |
| 72 | TERUMO CORPORATION | JP3546800008 | Not reported | 0.262% | $10.1M | Equity (common) | Corporate | Japan | JPY |
| 73 | INCYTE CORPORATION | US45337C1027 | 45337C102 | 0.247% | $9.5M | Equity (common) | Corporate | United States | USD |
| 74 | Fresenius SE & Co. KGaA | DE0005785604 | Not reported | 0.244% | $9.4M | Equity (common) | Corporate | Germany | EUR |
| 75 | VIATRIS INC. | US92556V1061 | 92556V106 | 0.240% | $9.2M | Equity (common) | Corporate | United States | USD |
| 76 | Celltrion, Inc. | KR7068270008 | Not reported | 0.231% | $8.9M | Equity (common) | Corporate | South Korea | KRW |
| 77 | GENMAB A/S | DK0010272202 | Not reported | 0.225% | $8.6M | Equity (common) | Corporate | Denmark | DKK |
| 78 | ZIMMER BIOMET HOLDINGS, INC. | US98956P1021 | 98956P102 | 0.217% | $8.4M | Equity (common) | Corporate | United States | USD |
| 79 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares BLACKROCK CASH FUNDS TREASURY | US0669224778 | 066922477 | 0.209% | $8.0M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 80 | Straumann Holding AG | CH1175448666 | Not reported | 0.193% | $7.4M | Equity (common) | Corporate | Switzerland | CHF |
| 81 | THE COOPER COMPANIES, INC. COOPER COS INC THE | US2166485019 | 216648501 | 0.182% | $7.0M | Equity (common) | Corporate | United States | USD |
| 82 | Shionogi & Co., Ltd. | JP3347200002 | Not reported | 0.178% | $6.8M | Equity (common) | Corporate | Japan | JPY |
| 83 | REVVITY, INC. | US7140461093 | 714046109 | 0.161% | $6.2M | Equity (common) | Corporate | United States | USD |
| 84 | SMITH & NEPHEW PLC | GB0009223206 | Not reported | 0.160% | $6.2M | Equity (common) | Corporate | United Kingdom | GBP |
| 85 | Roche Holding AG | CH0012032113 | Not reported | 0.157% | $6.0M | Equity (common) | Corporate | Switzerland | CHF |
| 86 | Sonova Holding AG | CH0012549785 | Not reported | 0.152% | $5.9M | Equity (common) | Corporate | Switzerland | CHF |
| 87 | OLYMPUS CORPORATION | JP3201200007 | Not reported | 0.152% | $5.8M | Equity (common) | Corporate | Japan | JPY |
| 88 | Siemens Healthineers AG | DE000SHL1006 | Not reported | 0.148% | $5.7M | Equity (common) | Corporate | Germany | EUR |
| 89 | SOLVENTUM CORPORATION | US83444M1018 | 83444M101 | 0.147% | $5.7M | Equity (common) | Corporate | United States | USD |
| 90 | ALIGN TECHNOLOGY, INC. | US0162551016 | 016255101 | 0.146% | $5.6M | Equity (common) | Corporate | United States | USD |
| 91 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | US1598641074 | 159864107 | 0.144% | $5.5M | Equity (common) | Corporate | United States | USD |
| 92 | BIO-TECHNE CORPORATION | US09073M1045 | 09073M104 | 0.144% | $5.5M | Equity (common) | Corporate | United States | USD |
| 93 | BAXTER INTERNATIONAL INC. | US0718131099 | 071813109 | 0.143% | $5.5M | Equity (common) | Corporate | United States | USD |
| 94 | SIGMA HEALTHCARE LIMITED SIGMA HEALTHCARE LTD | AU000000SIG5 | Not reported | 0.143% | $5.5M | Equity (common) | Corporate | Australia | AUD |
| 95 | INSULET CORPORATION | US45784P1012 | 45784P101 | 0.138% | $5.3M | Equity (common) | Corporate | United States | USD |
| 96 | Fresenius Medical Care AG FRESENIUS MEDICAL CARE AG CO KGAA | DE0005785802 | Not reported | 0.122% | $4.7M | Equity (common) | Corporate | Germany | EUR |
| 97 | EUROFINS SCIENTIFIC SE | FR0014000MR3 | Not reported | 0.116% | $4.5M | Equity (common) | Corporate | Luxembourg | EUR |
| 98 | HENRY SCHEIN, INC. | US8064071025 | 806407102 | 0.107% | $4.1M | Equity (common) | Corporate | United States | USD |
| 99 | Qiagen N.V. | NL0015002SN0 | Not reported | 0.104% | $4.0M | Equity (common) | Corporate | Netherlands | EUR |
| 100 | UNIVERSAL HEALTH SERVICES, INC. | US9139031002 | 913903100 | 0.101% | $3.9M | Equity (common) | Corporate | United States | USD |